November 25, 2025

Impact of Empirical Dietary Inflammatory Pattern on Survival Outcomes in Patients With Stage III Colon Cancer

Results from a large, prospective study show that eating a less inflammatory diet may reduce the risk of death for patients with stage III colon cancer.

The ASCO Post

November 13, 2025

Old Cancer Samples Yield New Genetic Insights

A University of Chicago team demonstrates at AMP 2025 that archival pathology samples can reveal cancer’s genetic evolution.

Conexiant

November 12, 2025

Radiation Training Levels May Influence Safety Culture

Researchers examine how radiation knowledge shapes health care safety attitudes.

Conexiant

November 11, 2025

ED drugs tied to lower gastric cancer risk

Large retrospective study finds 30% reduction in gastric malignancy among men taking erectile dysfunction medications.

Conexiant

November 06, 2025

CRC screening: Smartphone-based stool test matches lab accuracy

The findings point to a new tool for enhancing participation in CRC screening programs—particularly among younger, tech-savvy patients under 60 years who demonstrated higher adoption rates.

Conexiant

September 12, 2025

FDA Considers Ending Routine Advisory Committees on New Drugs

The FDA move to limit advisory committee involvement in drug approvals has prompted debate on the balance between efficiency and transparency.

KFF Health News

October 20, 2025

Colorectal cancer rising faster in younger adults worldwide

"Young adults appear to be at risk for presenting with more advanced stages of disease and more aggressive histologic characteristics than older patients.

Conexiant

October 27, 2025

Lower GI mistakes: Postop Crohn's, vaccine gaps, colonoscopy errors

"There's no such thing as a routine colonoscopy. Every colonoscopy has a potential for mistakes."

Conexiant

May 02, 2024

New NCI Grant to Foster Development of Novel Therapy in Metastatic Colorectal Cancer

The Case Western Reserve University School of Medicine received a 5-year $1.84 million grant to investigate the role of the LRG1 protein in colorectal cancer growth and develop a novel treatment option for patients with metastatic colorectal cancer.

Conexiant